MARS Bioimaging Secures $15M in Series A Funding Led by Pacific Channel to Expand Portable Spectral CT Scanners.
Amount Raised
$15 Million
Round Type
Series A
ChristchurchBiotechnologyHealth CareMedical DeviceInvestors
Description
MARS Bioimaging, a New Zealand-based innovator in medical imaging, has raised $15M in a Series A funding round led by Pacific Channel. The funds will help the company scale its portable spectral photon-counting CT scanners, transforming point-of-care diagnostics. This technology aims to provide high-resolution, 3D color images without traditional contrast agents, enhancing diagnostic capabilities significantly. The investment is crucial for MARS Bioimaging's global expansion efforts, especially in the U.S
Quick answer
MARS Bioimaging raised $15 Million in a Series A round, dated January 14, 2026. Investors: A Singapore Based Med Sector Firm and Pacific Channel. MARS Bioimaging is based in Christchurch, Canterbury, New Zealand.
- How much did MARS Bioimaging raise?
- MARS Bioimaging raised $15 Million in a Series A round on January 14, 2026.
- Who invested in MARS Bioimaging?
- A Singapore Based Med Sector Firm and Pacific Channel are named as investors in this round.
- What does MARS Bioimaging do?
- MARS Bioimaging is a New Zealand-based innovator in medical imaging technology.
- Where is MARS Bioimaging based and how big is it?
- MARS Bioimaging is based in Christchurch, Canterbury, New Zealand. Fundz records about 23 employees.
- Who are the decision-makers at MARS Bioimaging?
- Fundz holds 1 contact at MARS Bioimaging. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical Device and Biotechnology around the same time
Companies in the same sectors as MARS Bioimaging that raised within 45 days of this round, from Fundz verified event records.
- Blue Arbor Technologies raised $5M (Series A) on February 26, 2026.
- Abram Scientific raised $12M (Series A) on February 25, 2026.
- EMED Technologies raised $8M on February 25, 2026.
- Clee Medical raised an undisclosed amount (Seed) on February 25, 2026.
- ATRO Medical raised $3.5M (Seed) on February 25, 2026.
- Blue Arbor Technologies raised $10M on February 25, 2026.
Who to call at MARS Bioimaging, and when
A new round usually means MARS Bioimaging is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day MARS Bioimaging raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MARS Bioimaging, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MARS Bioimaging. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MARS Bioimaging raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMARS Bioimaging raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.